Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Toni-5
- Development stage
- Unknown
- Lead developer
- AGP
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Toni-5 is an oral combination nutritional tonic syrup developed and marketed by AGP in Pakistan. It is formulated to stimulate growth, improve appetite, and combat fatigue in both children and adults. Each 5 ml of the syrup contains a combination of active ingredients: lysine hydrochloride, calcium gluconoglucoheptonate, deanol pyroglutamate (dimethylaminoethanol pyroglutamate), phosphoric acid, and sorbitol. These components work synergistically to support muscle and bone tissue development, enhance cognitive function and mental alertness, and address nutritional deficiencies associated with anorexia, malnutrition, general weakness, and convalescence.
- Brand names
- Toni-5Toni5Toni 5
- Other names
- Toni 5Toni5Toni-5Toni-5 SyrupToni5 SyrupToni 5 Syrup
Beyond the preview
Go deeper on Toni-5.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Toni-5.